Scholarlink

Background <p>Pancreatic surgery is still associated with significant morbidity. In a simultaneously increasingly ageing population with elevated morbidity, the risk stratification and indications for surgery are of particular importance.</p> Objective <p>Assessment of the impact of multimorbidity of patients on the postoperative outcome after pancreatic surgery.</p> Material and methods <p>Evaluation and summary of the available literature.</p> Results <p>The postoperative morbidity after pancreatic surgery remains high. Relevant comorbidities, such as liver cirrhosis, cardiac and pulmonary diseases and advanced renal insufficiency enormously increase the risk of perioperative morbidity and mortality; however, in high-volume centers with appropriate expertise in pancreatic surgery the mortality is below 5%.</p> Conclusion <p>Pancreatic surgery with severe comorbidity can be safely performed in centers with proven expertise. Nevertheless, a careful interpretation of the indications and good patient selection are essential for the postoperative outcome.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Der multimorbide Patient – Risikostratifizierung und Indikationsstellung in der Pankreaschirurgie

  • 期刊论文

  • 发表日期：

    2025年1月6日

查看全文
  • Islam Labib,
  • Jürgen Weitz,
  • Sebastian Hempel

摘要

Background

Pancreatic surgery is still associated with significant morbidity. In a simultaneously increasingly ageing population with elevated morbidity, the risk stratification and indications for surgery are of particular importance.

Objective

Assessment of the impact of multimorbidity of patients on the postoperative outcome after pancreatic surgery.

Material and methods

Evaluation and summary of the available literature.

Results

The postoperative morbidity after pancreatic surgery remains high. Relevant comorbidities, such as liver cirrhosis, cardiac and pulmonary diseases and advanced renal insufficiency enormously increase the risk of perioperative morbidity and mortality; however, in high-volume centers with appropriate expertise in pancreatic surgery the mortality is below 5%.

Conclusion

Pancreatic surgery with severe comorbidity can be safely performed in centers with proven expertise. Nevertheless, a careful interpretation of the indications and good patient selection are essential for the postoperative outcome.